MICA Biosystems

About:

MICA Biosystems' uses nanotechnology to create remote controlled stem cells for regenerative medicine.

Website: https://www.micabiosystems.co.uk/

Top Investors: Innovate UK, European Commission

Description:

MICAs novel patented technology utilises magnetic nanoparticles to control cell behaviour inside and outside the body using custom designed and built magnetic arrays. Using this technology we have established a novel dynamic drug screening assay, DYNASCREEN. Further stem cell therapy applications have been explored with ambitions of clinical adoption for the treatment of bone and cartilage injuries. MICA scientists are experienced in functionalising magnetic nanoparticles with any antibody, peptide or small molecule to suit a range of applications.

Total Funding Amount:

$2.11M

Headquarters Location:

Birmingham, Birmingham, United Kingdom

Founded Date:

2010-01-01

Contact Email:

info(AT)micabiosystems.co.uk

Founders:

Alicia El Haj, Jon Dobson, Mike Zurawski

Number of Employees:

1-10

Last Funding Date:

2021-12-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai